Skip to content

EV / EBITDA at other companies

Lifevantage Corporation logo
Lifevantage CorporationLFVN
5.6×-5.1×
Herbalife logo
HerbalifeHLF
5.3×0.0×
BellRing Brands logo
BellRing BrandsBRBR
9.8×-13.3×
NuSkin Enterprises logo
NuSkin EnterprisesNUS
3.5×
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
8.5×+4.1×
NAG
Niagen Bioscience, Inc. Common StockNAGE
20.7×

Other financials

Income statement

See full
Revenue$25.3M+58.9%
Gross profit$9.5M+38.4%
Operating income$3.1M+3.5%
Net income$1.7M-14.8%
EPS (diluted)$0.17-15.0%

Balance sheet

See full
Cash & equivalents$1.2M-79.9%
Total debt$599.0K+52.4%
Total equity$45.4M+16.6%
Total assets$104.3M+67.7%

Cash flow

See full
Operating cash flow$2.5M+6.7%
CapEx--100%
Free cash flow$2.5M+7.8%

Valuation

See full
Market cap$103.4M-13.9%
Enterprise value$102.8M-13.6%
P/E16.1×+5.7×
P/S1.3×+0.1×

Profitability

See full
Gross margin40.7%-2.7pp
Operating margin15.1%-4.1pp
Net margin9.6%-3.8pp
FCF margin11.5%-4.5pp

Returns & leverage

See full
Return on equity17.8%-10.5pp
Debt / equity0.0×
Current ratio1.5×-0.1×

Where this comes from

Calculated from FitLife Brands, Inc.’s reported figures.

Based on the most recent quarter.

The official record: FitLife Brands, Inc.’s 10-Q, filed November 13, 2025, on SEC EDGAR. View the filing →

Ask your AI about FitLife Brands, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is FitLife Brands, Inc.'s EV / EBITDA?
FitLife Brands, Inc. (FTLF) reported EV / EBITDA of 18.2× in Q3 2025.
How has FitLife Brands, Inc.'s EV / EBITDA changed year-over-year?
FitLife Brands, Inc.'s EV / EBITDA increased by 51.7% year-over-year, from 12× to 18.2×.
What is the long-term trend for FitLife Brands, Inc.'s EV / EBITDA?
Over 4 years (2020 to 2024), FitLife Brands, Inc.'s EV / EBITDA has grown at a 32.4% compound annual growth rate (CAGR), from 3.9× to 12×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.